Compile Data Set for Download or QSAR
maximum 50k data
Found 70 of ic50 for UniProtKB: Q14957
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436102(CHEMBL2397256 | US10273214, Example 1180-26)
Affinity DataIC50:  800nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436101(CHEMBL2397257 | US10273214, Example 1180-27)
Affinity DataIC50:  1.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436082(CHEMBL2397103 | US10273214, Example 1391)
Affinity DataIC50:  1.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436090(CHEMBL2397119 | US10273214, Example 1180-31)
Affinity DataIC50:  1.20E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436072(CHEMBL2397211 | US10273214, Example 1426)
Affinity DataIC50:  2.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436078(CHEMBL2397109 | US10273214, Example 1180-12)
Affinity DataIC50:  2.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50503149(CHEMBL4464605)
Affinity DataIC50:  2.00E+3nMAssay Description:Negative allosteric modulation of GluN2C receptor (unknown origin) expressed in xenopus laevis oocytes assessed as reduction in glycine-induced chann...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436085(CHEMBL2397093 | US10273214, Example 1180-15)
Affinity DataIC50:  2.40E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50503153(CHEMBL4544421)
Affinity DataIC50:  2.60E+3nMAssay Description:Negative allosteric modulation of GluN2C receptor (unknown origin) expressed in xenopus laevis oocytes assessed as reduction in glycine-induced chann...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436067(CHEMBL2397233 | US10273214, Example 1366)
Affinity DataIC50:  3.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436079(CHEMBL2397108 | US10273214, Example 1180-10)
Affinity DataIC50:  3.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436060(CHEMBL2397100 | US10273214, Example 1390)
Affinity DataIC50:  3.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436061(CHEMBL2397099 | US10273214, Example 1368)
Affinity DataIC50:  4.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436083(CHEMBL2397097 | US10273214, Example 1425)
Affinity DataIC50:  5.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50503146(CHEMBL4447266)
Affinity DataIC50:  5.40E+3nMAssay Description:Negative allosteric modulation of GluN2C receptor (unknown origin) expressed in xenopus laevis oocytes assessed as reduction in glycine-induced chann...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436076(CHEMBL2397124 | US10273214, Example 1180-18)
Affinity DataIC50:  6.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436081(CHEMBL2397105 | US10273214, Example 1392)
Affinity DataIC50:  6.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436104(CHEMBL2397254 | US10273214, Example 1180-21)
Affinity DataIC50:  7.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436075(CHEMBL2397208 | US10273214, Example 1369)
Affinity DataIC50:  7.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50440056(CHEMBL2333944)
Affinity DataIC50:  7.00E+3nMAssay Description:Negative allosteric modulation of GluN2C receptor (unknown origin) expressed in xenopus laevis oocytes assessed as reduction in glycine-induced chann...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50324401((E)-4-(6-Methoxy-2-(3-nitrostyryl)-4-oxoquinazolin...)
Affinity DataIC50:  7.10E+3nMAssay Description:Negative allosteric modulation of GluN2C receptor (unknown origin) expressed in xenopus laevis oocytes assessed as reduction in glycine-induced chann...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436069(CHEMBL2397221 | US10273214, Example 1486)
Affinity DataIC50:  9.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50236939(CHEMBL2333945)
Affinity DataIC50: >1.00E+4nMAssay Description:Negative allosteric modulation of human GluN2C receptor expressed in xenopus laevis oocytes assessed as reduction in 3 uM glycine-induced channel cur...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436062(CHEMBL2397252 | US10273214, Example 1180-19)
Affinity DataIC50:  1.00E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436105(CHEMBL2397253 | US10273214, Example 1180-20)
Affinity DataIC50:  1.10E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50498439(CHEMBL1179566)
Affinity DataIC50:  1.20E+4nMAssay Description:Negative allosteric modulation of GluN2C receptor (unknown origin) expressed in xenopus laevis oocytes assessed as reduction in glycine-induced chann...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436084(CHEMBL2397095 | US10273214, Example 1180)
Affinity DataIC50:  1.20E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436064(CHEMBL2397250 | US10273214, Example 1180-25)
Affinity DataIC50:  1.20E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436080(CHEMBL2397107 | US10273214, Example 1180-16)
Affinity DataIC50:  1.30E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50379184(CHEMBL2010868)
Affinity DataIC50:  1.50E+4nMAssay Description:Negative allosteric modulation of GluN2C receptor (unknown origin) expressed in xenopus laevis oocytes assessed as reduction in glycine-induced chann...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM381963(US10273214, Example 1434)
Affinity DataIC50:  1.60E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM381958(US10273214, Example 1482)
Affinity DataIC50:  1.90E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM381957(US10273214, Example 1417)
Affinity DataIC50:  2.00E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM381961(US10273214, Example 1423)
Affinity DataIC50:  2.60E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50083351((+/-)-[2-(4-benzylpiperidino)-1-(4-hydroxyphenyl)-...)
Affinity DataIC50:  2.91E+4nMAssay Description:Negative allosteric modulation of human GluN2C receptor expressed in xenopus laevis oocytes assessed as reduction in 3 uM glycine-induced channel cur...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436074(CHEMBL2397209 | US10273214, Example 1180-11)
Affinity DataIC50:  3.10E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM381954(US10273214, Example 1418)
Affinity DataIC50:  3.30E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM381968(US10273214, Example 1563)
Affinity DataIC50:  3.90E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM381955(US10273214, Example 1421)
Affinity DataIC50:  4.10E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM53433(2-[(4-tert-butylbenzoyl)amino]-4-(4-methoxyphenyl)...)
Affinity DataIC50:  4.20E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM381960(US10273214, Example 1406)
Affinity DataIC50:  4.50E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50503145(CHEMBL4456824)
Affinity DataIC50:  5.00E+4nMAssay Description:Negative allosteric modulation of GluN2C receptor (unknown origin) expressed in xenopus laevis oocytes assessed as reduction in glycine-induced chann...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM381965(US10273214, Example 1433)
Affinity DataIC50:  5.10E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50086374(2-[3-(4-Benzyl-piperidin-1-yl)-propylsulfanyl]-1H-...)
Affinity DataIC50:  5.10E+4nMAssay Description:Antagonistic activity against NR1A/2C receptor in frog oocytesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50259886(CHEMBL2333943)
Affinity DataIC50:  6.80E+4nMAssay Description:Negative allosteric modulation of GluN2C receptor (unknown origin) expressed in xenopus laevis oocytes assessed as reduction in glycine-induced chann...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM81081(2-[(4-tert-butylbenzoyl)amino]-5,6-dihydro-4H-cycl...)
Affinity DataIC50:  7.70E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50086383(4-[2-(4-Benzyl-piperidin-1-yl)-ethylsulfanyl]-phen...)
Affinity DataIC50: >1.00E+5nMAssay Description:Antagonistic activity against NR1A/2C receptor in frog oocytesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50086369(2-(3-(4-benzylpiperidin-1-yl)propylthio)-5-methyl-...)
Affinity DataIC50: >1.00E+5nMAssay Description:Antagonistic activity against NR1A/2C receptor in frog oocytesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50086387(5-[2-(4-Benzyl-piperidin-1-yl)-ethylsulfanyl]-1H-[...)
Affinity DataIC50: >1.00E+5nMAssay Description:Antagonistic activity against NR1A/2C receptor in frog oocytesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50086384(5-[3-(4-Benzyl-piperidin-1-yl)-propylsulfanyl]-1H-...)
Affinity DataIC50: >1.00E+5nMAssay Description:Antagonistic activity against NR1A/2C receptor in frog oocytesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 70 total ) | Next | Last >>
Jump to: